|
|
Progress in Prevention of IFIs & Promise of New Diagnostic Techniques
|
Release Date: April 14, 2009
Credit Expiration Date: April 15, 2010
|
Credit Hours
Physician CME: 1.0
Pharmacist CPE: 1.0 (0.10 CEUs)
|
|
Activity Type
Knowledge-based and competence-based
|
This is the first activity in a 2-part series.
|
Educational Overview
When it comes to the management of invasive fungal infections (IFIs), a great deal of progress has been made with significant
advancements in prevention, diagnosis, and treatment. Promising new clinical data allow for more targeted antifungal
prophylaxis, identifying at-risk patients who would benefit most from this strategy. Evolving radiographic and serologic
diagnostic techniques enable clinicians to initiate therapy at the time when therapeutic intervention is most
effective. More options when determining treatment lead to better health outcomes for more patients at risk of or who have IFIs.
Today’s healthcare teams are more vigilant in anticipating the possibility of a fungal infection. As a result, survival
rates continue to increase while health outcomes improve. These positive efforts must continue. Clinicians, who acquire
a level of knowledge and familiarity with new prevention approaches, diagnostic techniques, and management strategies
for IFIs, will be empowered to make timely, accurate, evidence-based decisions that benefit their patients.
|
Target Audience
This activity has been developed for clinical pharmacists, infectious diseases physicians, hematologists/oncologists, and
transplant physicians responsible for the management of IFIs.
|
Purpose Statement
The purpose of this activity is to educate physicians and pharmacists involved in the management of patients at risk of
invasive fungal infections (IFIs) on prevention through the appropriate use of antifungal prophylaxis and early detection
using new diagnostic techniques. With this knowledge, healthcare professionals will be able to minimize the incidence of
IFIs and diagnose infection during the early stages.
|
Learning Objectives
At the conclusion of this activity, participant should be able to
- Assess the appropriate use of antifungal prophylaxis in immunocompromised patients
- Evaluate the utility of the latest diagnostic techniques for early detection of IFIs
|
Faculty
Pranatharthi H. Chandrasekar, MD
Professor of Medicine
Wayne State University School of Medicine
Detroit, MI
Richard H. Drew, PharmD, MS, BCPS
Professor, Campbell University School of Pharmacy
Associate Professor of Medicine (Infectious Diseases)
Duke University School of Medicine
Durham, NC
|
Accreditation
Physicians
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and
Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Center for
Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the ACCME to provide continuing
medical education for physicians.
Credit Designation: Center designates for this activity a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should
only claim credit commensurate with the extent of their participation in the activity.
This activity was originally released as a Live Webcast. Only those who did not claim credit for the live
activity can claim credit for this activity.
Pharmacists
Accreditation Statement: Center for Independent Healthcare Education (Center) is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation: Center has assigned 1.0 contact hour (0.10 CEUs) of continuing pharmacy education credit for
participation in this activity. ACPE Universal Activity Number: 473-999-09-006-H01-P
This activity was originally released as a Live Webcast with ACPE Universal Activity Number: 473-999-09-001-L01-P.
Only those who did not claim the credit for the live activity can claim credit for this activity
Estimated time to complete activity: 1.0 hour
|
Method of Participation and Instruction for Credit
- Review the entire CME/CE information including target audience, learning objectives, and disclosures.
- Review the On-Demand Webcast in its entirety.
- Print and complete the Post Test, Evaluation, and Credit Application form.
- Mail the completed Post Test, Evaluation, and Credit Application form to Vemco MedEd, 245 US Highway 22, Suite 304, Bridgewater, NJ 08807 Or Fax to (908) 235-4222.
Documentation of credit will be mailed within 4 weeks of receipt of the completed Post Test, Evaluation, and Credit Application form.
|
Disclosures
Center for Independent Healthcare Education requires faculty, planners, and others who are in a position to control the
content of continuing education activities to disclose to the audience any real or apparent conflict of interest
related to the activity. All identified conflicts of interest are reviewed to ensure fair balance, objectivity, and scientific
rigor in all activities. The faculty is further required to disclose discussion of off-label uses in their presentations.
Faculty
Pranatharthi H. Chandrasekar, MD
Research/Grant Support: Pfizer
Advisory Boards: Basilea and Pfizer
Speakers Bureaus: Schering-Plough, Astellas, Merck, Pfizer, and Enzon
Richard H. Drew, PharmD, MS, BCPS
Consultant: Merck, Theravance, Schering-Plough, Forest, Wyeth-Ayerst, and Ortho-McNeil
Research Support: Schering-Plough, NeuTec, and Cubist
Speaker Honoraria: Schering-Plough, Ortho-McNeil, Enzon, and Astellas
Development Team: CustomID
Planning Committee Members
Employees of Center for Independent Healthcare Education and Vemco MedEd have no relevant financial relationships to disclose.
Off-label Use Disclosure
In this activity, off-label use of the following antifungal agents is discussed: itraconazole
(for prophylaxis), caspofungin (for prophylaxis), voriconazole (for prophylaxis), and aerosolized formulations
of amphotericin B (for prophylaxis).
|
Joint Sponsorship
This activity is jointly sponsored by Center for Independent Healthcare Education and Vemco MedEd.
|
Commercial Support
This activity is supported by an educational grant from Schering-Plough Corporation.
|
Fee
There is no fee associated with this activity.
|
Hardware/Software Requirements
Web Browser
Internet Explorer or Mozilla
Note: Please disable any “pop-up blocker” features.
Software
Flash Player to view the presentations
Adobe Acrobat Reader version 4 or above to view PDF files (If you do not have Acrobat Reader, you can download it
for free from http://get.adobe.com/reader)
Connection Speed
Cable, DSL, or better of at least 300 kbps
Hardware
PC or Apple to view the presentations
Audio Speakers
System Check
Please e-mail any questions or concerns to info@vemcomeded.com.
|
Copyright Statement
Copyright © 2009 Vemco MedEd, LLC. All Rights Reserved.
Permission for accreditation use granted to Center for Independent Healthcare Education.
|
Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Center for
Independent Healthcare Education (Center) and Vemco MedEd. This educational activity may discuss off-label and/or investigational
uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug
Administration (FDA). Center and Vemco MedEd do not recommend the use of any product/procedure outside of the labeled
indications. A qualified healthcare professional should be consulted before using any therapeutic product/procedure
discussed. Clinicians should verify all information and data before treating patients or employing any therapies
described in this continuing education activity. Please refer to the prescribing information for each
product/procedure for approved indication, contraindications, and warnings.
|
Privacy Policy
http://www.vemcomeded.com/privacy.asp
|
Contact Information
For questions regarding the accreditation of this activity, please contact Center for Independent Healthcare
Education at info@jointsponsor.com
|
Start Activity
|
By clicking on the icon to begin the educational activity, I acknowledge that I have read the entire CME/CPE information.
|
|
|
|
|
|